Structure |
Chemical Name |
CAS |
MF |
|
Roscovitine |
186692-46-6 |
C19H26N6O |
|
Tozasertib |
639089-54-6 |
C23H28N8OS |
|
MLN-8237 |
1028486-01-2 |
C27H20ClFN4O4 |
|
Danusertib |
827318-97-8 |
C26H30N6O3 |
|
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- |
722544-51-6 |
C26H30FN7O3 |
|
AZD 5438 |
602306-29-6 |
C18H21N5O2S |
|
SNS-032 |
345627-80-7 |
C17H24N4O2S2 |
|
BI 2536 |
755038-02-9 |
C28H39N7O3 |
|
3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-Thiophenecarboxamide |
860352-01-8 |
C17H19FN4O2S |
|
Thiazovivin |
1226056-71-8 |
C15H13N5OS |
|
Y27632 (hydrochloride) |
129830-38-2 |
C14H23Cl2N3O |
|
N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide |
864082-47-3 |
C21H16F4N4O2 |
|
Volasertib (BI 6727) |
755038-65-4 |
C34H50N8O3 |
|
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide |
587841-73-4 |
C21H19BrClN5O4S2 |
|
PHA-793887 |
718630-59-2 |
C19H31N5O2 |
|
[4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone(R 547) |
741713-40-6 |
C18H21F2N5O4S |
|
FLAVOPIRIDOL HYDROCHLORIDE |
131740-09-5 |
C21H21Cl2NO5 |
|
JNJ-7706621 |
443797-96-4 |
C15H12F2N6O3S |
|
PHA 767491 HYDROCHLORIDE |
845714-00-3 |
C12H11N3O |
|
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE |
869363-13-3 |
C25H15ClF2N4O2 |
|
CYC-116 |
693228-63-6 |
C18H20N6OS |
|
PHA-680632 |
398493-79-3 |
C28H35N7O2 |
|
PF 477736 |
952021-60-2 |
C22H25N7O2 |
|
CCT129202 |
942947-93-5 |
C23H25ClN8OS |
|
PF-03814735 |
942487-16-3 |
C23H25F3N6O2 |
|
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
|
PD0332991 Isethionate |
827022-33-3 |
C26H35N7O6S |
|
Hesperadin |
422513-13-1 |
C29H32N4O3S |
|
SD208 (TGF-Β/SMAD inhibitor) |
|
|
|
SU 9516 |
377090-84-1 |
C13H11N3O2 |
|
HMN-214 |
173529-46-9 |
C22H20N2O5S |
|
CHIR-124 |
405168-58-3 |
C23H22ClN5O |
|
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
|
P276 |
920113-03-7 |
C21H21Cl2NO5 |
|
Ribociclib |
1211441-98-3 |
C23H30N8O |
|
NU 6027 |
220036-08-8 |
C11H17N5O2 |
|
GSK1070916 |
942918-07-2 |
C30H33N7O |
|
RKI1447 |
1342278-01-6 |
C16H14N4O2S |
|
(Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE |
403811-55-2 |
C12H11NOS2 |
|
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
|
TG003 |
300801-52-9 |
C13H15NO2S |
|
GSK461364 |
929095-18-1 |
C27H28F3N5O2S |
|
Aurora A Inhibitor I |
1158838-45-9 |
C31H31ClFN7O2 |
|
MK-5108 (VX-689) |
1010085-13-8 |
C22H21ClFN3O3S |
|
CCT 137690 |
1095382-05-0 |
C26H31BrN8O |
|
SCH900776 |
891494-63-6 |
C15H18BrN7 |
|
MLN0905 |
1228960-69-7 |
C24H25F3N6S |
|
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
|
AMG 900 |
945595-80-2 |
C28H21N7OS |
|
ZM 447439 |
331771-20-1 |
C29H31N5O4 |
|
PHA-848125 |
802539-81-7 |
C25H32N8O |
|
LY2603618 |
911222-45-2 |
C18H22BrN5O3 |
|
XL413 (BMS-863233) |
1169562-71-3 |
C14H13Cl2N3O2 |
|
Salirasib |
162520-00-5 |
C22H30O2S |
|
EHT1864 |
754240-09-0 |
C25H27F3N2O4S2HCl |
|
NMS-P937 (NMS1286937) |
1034616-18-6 |
C24H27F3N8O3 |
|
LDC000067 |
1073485-20-7 |
C18H18N4O3S |
|
BS-181 HCl |
1397219-81-6 |
C22H33ClN6 |
|
1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one |
1469337-95-8 |
C15H17ClIN3O3 |
|
K-Ras(G12C) inhibitor 6 |
2060530-16-5 |
C17H22Cl2N2O3S |
|
NSC 23766 (hydrochloride) |
1177865-17-6 |
C24H35N7 |
|
K-Ras(G12C) inhibitor 9 |
1469337-91-4 |
C16H21ClIN3O4S |
|
CCG-1423 |
285986-88-1 |
C18H13ClF6N2O3 |
|
MK8745 |
885325-71-3 |
C20H19ClFN5OS |
|
ML167 |
1285702-20-6 |
C19H17N3O3 |
|
ML 141 |
71203-35-5 |
C22H21N3O3S |
|
SBE 13 hydrochloride |
1052532-15-6 |
C24H28Cl2N2O4 |
|
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine |
1380432-32-5 |
C25H30N6O |
|
Ro 3306 |
872573-93-8 |
C18H13N3OS2 |
|
RO3280 |
1062243-51-9 |
C27H35F2N7O3 |
|
K-Ras inhibitor |
1469338-01-9 |
C20H30ClN3O2S3 |